CIR
AZN icon

Clear Investment Research’s AstraZeneca AZN Stock Holding History

Clear Investment Research’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.6K Buy
+140
New +$27K 0.04% 137
2025
Q4 		– Sell
-140
Closed -$21.5K – 67
2025
Q3 		$21.5K Hold
140
– – 0.03% 157
2025
Q2 		$19.6K Hold
140
– – 0.02% 147
2025
Q1 		$20.6K Hold
140
– – 0.03% 140
2024
Q4 		$18.3K Hold
140
– – 0.02% 143
2024
Q3 		$21.8K Hold
140
– – 0.03% 139
2024
Q2 		$21.8K Hold
140
– – 0.03% 131
2024
Q1 		$19K Hold
140
– – 0.03% 139
2023
Q4 		$18.9K Hold
140
– – 0.03% 151
2023
Q3 		$19K Hold
140
– – 0.03% 113
2023
Q2 		$20K Hold
140
– – 0.03% 116
2023
Q1 		$19.4K Hold
140
– – 0.03% 113
2022
Q4 		$19K Hold
140
– – 0.04% 107
2022
Q3 		$15K Buy
+140
New +$17.8K 0.03% 109

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM